AURORA: Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical Margins

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Completed
CT.gov ID
NCT05960669
Collaborator
Intuitive Surgical (Industry)
100
1
1
48.8
2

Study Details

Study Description

Brief Summary

To optimize precision for secondary resection (SR) in frozen section (FS) controlled nerve-sparing robot-assisted radical prostatectomy (NS-RARP) by using a personalized 3D-printed prostate model.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 3D model guided secondary resection
N/A

Detailed Description

Background:

Nerve-sparing (NS) robot-assisted radical prostatectomy (RARP) offers optimized oncological and functional outcomes and has become the preferred minimally-invasive approach when available. To maximize oncologic safety in NS-RARP, a frozen section (FS) can be used but does not provide a visual impression of the positive surgical margin (PSM) to guide secondary resection (SR).

Objective:

To optimize precision for secondary resection (SR) in frozen section (FS) controlled nerve-sparing robot-assisted radical prostatectomy (NS-RARP) by using a personalized 3D-printed prostate model.

Design, setting and participants:

100 patients with NS-RARP performed between September 2018 and August 2021 were included in this prospective multicenter cohort study.

Interventions:

A prostate model was 3D printed from preoperative pelvic MRI data and used during surgery to mark a PSM and guide SR.

Outcome Measurements and statistical analysis Endpoints were comparison of the primary surgical margin status in the FS with the tissue of the resulting SR and with the final surgical margin status. Secondary parameters for oncological and erectile outcomes were assessed before and one year after surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Cohort StudyCohort Study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical Margins
Actual Study Start Date :
Aug 1, 2018
Actual Primary Completion Date :
Aug 26, 2021
Actual Study Completion Date :
Aug 26, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: 3D model guided SR

A prostate model was 3D printed from preoperative pelvic MRI data and used during surgery to mark a positive surgical margin and guide secondary resection.

Procedure: 3D model guided secondary resection
A prostate model was 3D printed from preoperative pelvic MRI data and used during robot-assisted radical prostatectomy to mark a positive surgical margin and guide secondary resection.

Outcome Measures

Primary Outcome Measures

  1. comparison of the primary surgical margin status in the FS with the tissue of the resulting SR and with the final surgical margin status [4 weeks]

Secondary Outcome Measures

  1. Erectile function [1 year]

    IIEF-5

  2. Oncologic follow-up [1 year]

    PSA Monitoring

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • preoperatively planed and intraoperatively performed nerve-sparing approach (at least unilateral)

  • suitable pelvic MRI for the creation of a personalized 3D prostate model,

  • written patient consent

Exclusion Criteria:
  • no nerve sparing performed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsspital Basel Urologie Basel Switzerland 4031

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland
  • Intuitive Surgical

Investigators

  • Principal Investigator: Christian CE Engesser, Dr., University Hospital, Basel, Switzerland
  • Principal Investigator: Jan JE Ebbing, PD Dr. med, University Hospital, Basel, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT05960669
Other Study ID Numbers:
  • AURORA_2018
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023